Tuncay Göksel

19.5k total citations · 1 hit paper
69 papers, 3.5k citations indexed

About

Tuncay Göksel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biomedical Engineering. According to data from OpenAlex, Tuncay Göksel has authored 69 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 15 papers in Biomedical Engineering. Recurrent topics in Tuncay Göksel's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Lung Cancer Research Studies (18 papers). Tuncay Göksel is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Lung Cancer Research Studies (18 papers). Tuncay Göksel collaborates with scholars based in Türkiye, United States and South Korea. Tuncay Göksel's co-authors include Giorgio V. Scagliotti, Keunchil Park, Janusz Rolski, U. Gatzemeier, Mauro Zukin, Christian Manegold, Anders Mellemgaard, Piotr Serwatowski, Lorinda Simms and Purvish Parikh and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Tuncay Göksel

63 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

2008 2.5k citations Giorgio V. Scagliotti, Purvish Parikh et al. Journal of Clinical Oncology profile →

Peers

Tuncay Göksel

PRM

ONCOL

Purvish M. Parikh India

Antonio Passaro Italy

Alfredo Addeo Switzerland

Robert C. Rintoul United Kingdom

Luís Manso Spain

Urban Emmenegger Canada

Á. Artal Spain

W. Jeffrey Petty United States

Kostas Syrigos Greece

Vasilios Karavasilis Greece

Purvish M. Parikh India

Tuncay Göksel

2.6k ×1.1

PRM

2.6k ×1.3

ONCOL

952 ×1.2

587 ×1.2

128 ×0.4

Citations per year, relative to Tuncay Göksel Tuncay Göksel (= 1×) peers Purvish M. Parikh

Countries citing papers authored by Tuncay Göksel

Since Specialization

Citations

This map shows the geographic impact of Tuncay Göksel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuncay Göksel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuncay Göksel more than expected).

Fields of papers citing papers by Tuncay Göksel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuncay Göksel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuncay Göksel. The network helps show where Tuncay Göksel may publish in the future.

Co-authorship network of co-authors of Tuncay Göksel

This figure shows the co-authorship network connecting the top 25 collaborators of Tuncay Göksel. A scholar is included among the top collaborators of Tuncay Göksel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuncay Göksel. Tuncay Göksel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Göksel, Tuncay, et al.. (2025). Update: The New 9th Edition TNM Classification for Lung Cancer Is Now in Use. PubMed. 27(1). 47–56.

Vardarli, Aslı Teti̇k, et al.. (2025). Assessment of Exhaled Breath Condensate for ALK, RET, ROS1, and NTRK1 Fusion Transcript Detection in NSCLC: Comparison With Tissue and Liquid Biopsy Samples. Thoracic Cancer. 16(1). e15513–e15513.

Göksel, Tuncay, Su Özgür, Aslı Teti̇k Vardarli, et al.. (2024). Prognostic and predictive role of liquid biopsy in lung cancer patients. Frontiers in Oncology. 13. 1275525–1275525. 2 indexed citations

Beduk, Duygu, Tutku Bedük, Veerappan Mani, et al.. (2024). Multiplexed aptasensor for detection of acute myocardial infraction (AMI) biomarkers. Sensors & Diagnostics. 3(6). 1020–1027. 8 indexed citations

Ghorbanizamani, Faezeh, Hichem Moulahoum, Emine Guler, et al.. (2023). Design of Polymeric Surfaces as Platforms for Streamlined Cancer Diagnostics in Liquid Biopsies. Biosensors. 13(3). 400–400. 7 indexed citations

Asadi, Milad, et al.. (2023). Salivary Lipids of Patients with Non-Small Cell Lung Cancer Show Perturbation with Respect to Plasma. International Journal of Molecular Sciences. 24(18). 14264–14264. 4 indexed citations

Durmus, Ceren, Hichem Moulahoum, Faezeh Ghorbanizamani, et al.. (2022). Indiscriminate SARS-CoV-2 multivariant detection using magnetic nanoparticle-based electrochemical immunosensing. Talanta. 243. 123356–123356. 27 indexed citations

Ghorbanizamani, Faezeh, Hichem Moulahoum, Emine Guler, et al.. (2022). Fluorescent bioassay for SARS-CoV-2 detection using polypyrene-g-poly(ε-caprolactone) prepared by simultaneous photoinduced step-growth and ring-opening polymerizations. Microchimica Acta. 189(5). 202–202. 12 indexed citations

Beduk, Duygu, José Ilton de Oliveira Filho, Tutku Bedük, et al.. (2022). 'All In One' SARS-CoV-2 variant recognition platform: Machine learning-enabled point of care diagnostics. Biosensors and Bioelectronics X. 10. 100105–100105. 34 indexed citations

10.

Ghosh, Manosij, et al.. (2020). Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review. International Journal of Environmental Research and Public Health. 17(3). 1110–1110. 19 indexed citations

11.

Vardarli, Aslı Teti̇k, Levent Pelit, Ayça Aykut, et al.. (2020). ^* Concordance in molecular genetic analysis of tumour tissue, plasma, and exhaled breath condensate samples from lung cancer patients. Journal of Breath Research. 14(3). 36001–36001. 9 indexed citations

12.

Mazières, Julien, Sara M. Tolaney, Luis Paz‐Ares, et al.. (2017). P2.06-012 Phase 2 Study of Abemaciclib + Pembrolizumab in KRAS Mutation, PD-L1+, Stage IV Non-Small Cell or Squamous Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S1076–S1077. 2 indexed citations

13.

Göksel, Tuncay, Sultan Eser, Salih Zeki Güçlü, et al.. (2013). Prognostic factors affecting survival in cases with lung cancer [A lung cancer mapping project in Turkey (LCMPT)]. European Respiratory Journal. 42(Suppl 57). P2920–P2920. 5 indexed citations

14.

Scagliotti, Giorgio V., Keunchil Park, Shekar Patil, et al.. (2009). Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study. European Journal of Cancer. 45(13). 2298–2303. 32 indexed citations

15.

Scagliotti, Giorgio V., Purvish Parikh, Joachim von Pawel, et al.. (2008). Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(21). 3543–3551. 2487 indexed citations breakdown →

16.

Göksel, Tuncay, Osman Nuri Hatipoğlu, Can Öztürk, et al.. (2005). A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non‐small cell lung cancer. Respirology. 10(4). 456–463. 5 indexed citations

17.

Göksel, Tuncay, et al.. (2005). Success of a Smoking Cessation Program among Smoking Relatives of Patients with Serious Smoking-Related Pulmonary Disorders. European Addiction Research. 11(2). 57–61. 11 indexed citations

18.

Göksel, Tuncay, et al.. (2002). Sigara ile ilişkili ciddi akciğer hastalığı olanların sigara içen yakınlarında sigara bırakma tedavisinin başarısı. 3(3). 248–252. 2 indexed citations

19.

Göksel, Tuncay, et al.. (2001). İzmir ili lise öğrencilerinin sigara alışkanlığını etkileyen faktörler. 2(3). 49–53. 4 indexed citations

20.

Çok, Gürsel, et al.. (2001). Primer ve sekonder spontan pnömotorakslı olguları karşılaştıran geriye dönük bir çalışma. 2(2). 18–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact